ASX:HSO

Healthscope (HSO) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
38.30 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.86%
Price Target
N/A

About Healthscope

Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia.

HSO Stock News Headlines

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
4 top growth shares I’d buy today
See More Headlines
Receive HSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthscope and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2019
Today
4/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
17,100
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Outstanding Shares
1,748,630,016
Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Gordon Scott Ballantyne (Age 54)
    MD, CEO & Director
  • Mr. Michael Sammells
    Chief Financial Officer
  • Mr. Mark Briscoe
    Gen. Mang. of Operations
  • Mr. David Shirer
    Gen. Mang. of Investor Relations
  • Ms. Ingrid A. Player (Age 46)
    Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec.

HSO Stock Analysis - Frequently Asked Questions

How were Healthscope's earnings last quarter?

Healthscope Ltd (ASX:HSO) issued its quarterly earnings data on Thursday, February, 14th. The company reported $0.04 earnings per share (EPS) for the quarter.

Is Healthscope a good dividend stock?

Healthscope (ASX:HSO) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 2.86%.
Read our dividend analysis for HSO.

What other stocks do shareholders of Healthscope own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthscope investors own include UBS ETRACS CMCI Energy Total Return ETN (UBN), Primary Health Care (PRY) and Fortescue (FMG).

This page (ASX:HSO) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners